CT scans of 37 Egyptian mummies found strong correlations between oral disease and calcified blood vessels, offering new evidence that the link between dental and cardiovascular health spans 4,000 years of human history.

Treatment options are limited for the more than 500,000 people in the U.S. who are diagnosed annually with C. diff infections, but researchers are working on potential vaccines, therapeutic antibodies and — most recently — nanobodies, to prevent and treat C. diff infections.

There currently are no approved treatments or vaccines to protect against the infection, which can cause internal bleeding, organ failure, and in roughly 50% of cases, death.

Researchers at Vanderbilt Health and around the country continue to evaluate the effectiveness of vaccines approved by the Food and Drug Administration to reduce the severity and lethality of respiratory infections caused by the ever-mutating SARS-CoV-2 virus.

The latest findings could lead to more targeted ways to increase insulin-stimulated glucose uptake by muscle and exercise tolerance.

Since 2014, 27 Vanderbilt faculty members have received the annual award, which recognizes “notable achievements” by researchers early in their first faculty appointments.